NCT02542618

Brief Summary

Background: Major depression is a common mental disorder with serious consequences. The societal costs of depression are high. Despite the existence of empirically-supported psychological therapies, many patients do not benefit from these treatments and relapse and recurrence percentages are high. Improvement of existing treatments or development of new and better treatments is badly needed. Inquiry Based Stress Reduction (IBSR) is a promising verbal therapy focusing on the inquiry of thoughts and could be a next step in improving psychotherapy for depression. Objective: The objective of the current study is to assess the effectiveness of IBSR. Research to date has shown that IBSR is effective in reducing symptoms of anxiety and depression. The investigators want to know if IBSR is more effective in reducing symptoms of depression than the best psychotherapeutic treatment for depression at this moment, cognitive behavioural therapy (CBT). The investigators' secondary objective is to know more about the underlying mechanisms of change of these therapies. Study design: A randomized controlled intervention study. Study population: 88 patients with a mild to moderate depression as their principal diagnosis. Intervention: IBSR or CBT

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
88

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started Oct 2015

Longer than P75 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 2, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 7, 2015

Completed
24 days until next milestone

Study Start

First participant enrolled

October 1, 2015

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2018

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
Last Updated

September 13, 2018

Status Verified

September 1, 2018

Enrollment Period

3 years

First QC Date

September 2, 2015

Last Update Submit

September 12, 2018

Conditions

Keywords

DepressionTreatmentIBSRCBT

Outcome Measures

Primary Outcomes (1)

  • Beck Depression Inventory (BDI-II) to measure change from baseline self-reported symptoms of depression at the endpoint of the therapy (after completing 16 sessions) and follow-ups.

    The BDI-II is a self-report questionnaire which measures the severity of depression in 21 statements, with four levels of increasing severity each. The investigators use the BDI-II to measure self-reported symptoms of depression.

    At pre (baseline) and session 16 (post) and follow-up (after 1 and 2 years) measurements.

Secondary Outcomes (8)

  • Symptom Questionnaire (SQ-48) to measure change in self-reported general psychological distress from baseline at session 8, session 16 (end of therapy) and follow-ups

    At pre (baseline), session 8 and 16 (post) and follow-up (after 1 and 2 years) measurements.

  • Short Form Health Survey (SF-36) to measure change from baseline self-reported quality of life at the endpoint of the therapy (after completing 16 sessions) and follow-ups

    At pre (baseline), session 16 (post) and follow-up (after 1 and 2 years) measurements.

  • The Structured Clinical Interview for Diagnostic and Statistical Manual-IV (DSM-IV) Axis I Disorders (SCID-I) Dutch version to screen for Diagnostic and Statistical Manual of Mental Disorder (DSM-IV) diagnoses

    At pre (baseline), session 16 (post) and follow-up (after 1 and 2 years) measurements.

  • Acceptance and Action Questionnaire-II (AAQ-II) to measure change in self-reported level of general psychological acceptance from baseline at every fourth therapy session and follow-ups

    At pre (baseline), session 4,8, 12 and 16 (post) and follow-up (after 1 and 2 years) measurements.

  • Dysfunctional Attitude Scale, 17-item Dutch version (DAS-A-17) to measure change in self-reported level of dysfunctional thinking from baseline at every fourth therapy session and follow-ups

    At pre (baseline), session 4,8, 12 and 16 (post) and follow-up (after 1 and 2 years) measurements.

  • +3 more secondary outcomes

Study Arms (2)

Inquiry Based stress Reduction (IBSR)

EXPERIMENTAL

IBSR intervention is the clinical implementation of a mindful-process, named "The Work" developed by Byron Katie. It teaches the individual to identify and question the thoughts that causes stress and suffering through four questions and turnarounds.

Behavioral: Inquiry Based Stress Reduction (IBSR)

Cognitive Behavioral Therapy (CBT)

ACTIVE COMPARATOR

CBT is a psychological treatment method, focusing on a structured way to identify and modify unhelpful thinking patterns, underlying assumptions and idiosyncratic cognitive schemes about the self, the world (including other people) and the future.

Behavioral: Cognitive Behavioral Therapy (CBT)

Interventions

Also known as: The Work
Inquiry Based stress Reduction (IBSR)
Cognitive Behavioral Therapy (CBT)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years and older,
  • Not making use of other treatment for depression at the time,
  • No history of psychotherapy in the last year,
  • No medication for depression or unchanged dosage of medication during the last two months ,
  • All participants must be willing to refrain from engaging in additional psychological treatments or making changes to their medication status during the course of the trial. (changes in medication dosage will result in dropout),
  • All participants must have at least a low average level of intelligence (IQ above 80). During regular intakes a clinical judgment is made. This is in accordance with the standard protocols used within the FortaGroep.
  • All participants are required to have sufficient knowledge of the Dutch language.

You may not qualify if:

  • Active suicidal intent (which is asked during the interviews and further operationalized with help of the ninth item in the BDI-II at pre-treatment: If patients marked the statement ''I would kill myself if I could'', they are classified as being at risk of suicide)
  • If the DSM-IV criteria for severe major depressive disorder, psychotic disorder, or bipolar disorder are met
  • A mental impairment or neurocognitive disorders such as Alzheimer
  • Substance abuse requiring specialist treatment
  • No time for homework.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

FortaGroep

Rotterdam, South Holland, 3067GK, Netherlands

Location

MeSH Terms

Conditions

Depression

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Clinical Psychology

Study Record Dates

First Submitted

September 2, 2015

First Posted

September 7, 2015

Study Start

October 1, 2015

Primary Completion

October 1, 2018

Study Completion

March 1, 2020

Last Updated

September 13, 2018

Record last verified: 2018-09

Locations